SerpApi.Org
Check your medicine cabinet ASAP.
Key Points
- A nationwide recall was issued for 5-milligram cetirizine tablets due to cross-contamination concerns.
- The tablets may be contaminated with ranitidine, a drug used to treat ulcers and digestive conditions.
- Consumers should dispose of or return affected products and contact Rising Pharma for questions or refunds.
There’s an active recall on a specific allergy medication sold nationwide, according to the U.S. Food and Drug Administration (FDA). This is due to cross contamination.
The product recalled is 5-milligram cetirizine hydrochloride tablets with printed expiration date “10/2028” and one of the following lot codes: GY825029, GY825030, GY825031 or GY825032.
Manufactured by Unique Pharmaceutical Laboratories, the product was distributed and sold at the consumer level nationwide. Check your cabinets, and if you have this medication on hand, dispose of it or return to your place of purchase for a possible refund or replacement.
The allergy relief medication is being recalled because it may be cross-contaminated with ranitidine, a medication used to treat ulcers and digestive conditions such as gastroesophageal reflux disease (GERD). If you are experiencing any reactions or health concerns after consuming the mixed pills, seek immediate medical attention.
For questions about this recall, contact distributor Rising Pharma Holdings Inc. by emailing [email protected] or [email protected], or by calling 1-844-874-7464 Monday through Friday from 8 a.m. to 5 p.m. ET.
Read the original article on EatingWell
